Kevin Jessing has been appointed director of Bioanalytical Services at ABC Laboratories, Inc. Mr. Jessing will oversee the operations of the Bioanalytical Services group and lead the team’s R&D efforts for the pharmaceutical, biotech and animal health industries.

Mr. Jessing has 15 years of industry experience as a drug discovery/development scientist, as well as building teams in both the CRO and pharmaceutical environment. Prior to joining ABC, he worked in various executive positions, including chief operating officer of GEL Analytics, vice president of bioanalytical services for Lifetree Bioanalytical, co-founder, president and chief executive officer for Resonance Laboratories, and executive director of business development for Lifetree Clinical Research.

Also, Frank White, Ph.D., has been appointed director of DMPK and Synthesis. Dr. White directs the ongoing operations for the DMPK and Synthesis groups and leads the teams’ R&D efforts.

Dr. White has 22 years of experience in the industry with a focus on the conceptualization, synthetic pathway design, process evaluation and preparation of radiolabeled and stable-labeled molecules for use in product development and registration studies. Prior to joining the company, he worked for Eli Lilly and Co. and Dow AgroSciences.